tailieunhanh - Management and treatment of relapsed or refractory Ph(−) B-precursor ALL: A webbased, double-blind survey of EU clinicians

The prognosis for adult patients with Ph(-) B-precursor acute lymphoblastic leukaemia (ALL) who are refractory to treatment or experience relapse (R/R), is poor; over 90 % of these patients die from the disease, typically within a few months. While there are some national guidelines published for the treatment of adult patients with ALL, and local working group recommendations do exist, there is very little detail and no preferred treatment regimens for adult patients with R/R Ph(-) B-precursor ALL. |

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN